The underlying mechanism could be the significant recruitment of DEXOB16+pIC in the tumor‐draining lymph nodes, leading to significant activation of B16F10‐specific effector CD8+ TCs and homing of effector TCs, NKCs, and NK‐TCs to the tumor site.[189]. Here, CD8A is linked to neoplasm.